Austin, Texas
United States
39
2024-10-31
25
2026-05-26
These are the the leading inventors for applications assigned to Molecular Templates, Inc.:
Molecular Templates, Inc. based in Austin, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#2 | 2024-03-21 ✅ Patent 12,180,262 granted on 2024-12-31CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors
#3 | 2022-12-22CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#4 | 2022-09-29 ✅ Patent 12,037,367 granted on 2024-07-16MHC class I epitope delivering polypeptides
#5 | 2022-09-01 ✅ Patent 12,065,469 granted on 2024-08-20De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals
#6 | 2022-07-19 ✅ Patent 11,389,542 granted on 2022-07-19Shiga toxin a subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
#7 | 2022-06-23 ✅ Patent 12,180,284 granted on 2024-12-31Clinical methods for use of a PD-L1-binding molecule comprising a Shiga toxin effector
#8 | 2022-05-19 ✅ Patent 11,857,628 granted on 2024-01-02Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
#9 | 2021-09-02 ✅ Patent 11,406,692 granted on 2022-08-09Cell-targeting molecules comprising de-immunized, Shiga toxin a subunit effectors and CD8+ t-cell epitopes
#10 | 2021-08-19 ✅ Patent 11,365,223 granted on 2022-06-21De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same
#11 | 2021-08-19 ✅ Patent 11,312,751 granted on 2022-04-26MHC class I epitope delivering polypeptides
#12 | 2021-05-13CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#13 | 2021-03-18 ✅ Patent 11,136,395 granted on 2021-10-05PD-L1 -binding molecules comprising Shiga toxin A subunit scaffolds
#14 | 2021-03-18 ✅ Patent 11,918,649 granted on 2024-03-05PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds
#15 | 2021-02-11 ✅ Patent 11,225,509 granted on 2022-01-18HER2-targeting molecules comprising de-immunized, Shiga toxin A subunit scaffolds
#16 | 2021-01-21CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES
#17 | 2021-01-14SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES, SHIGA TOXIN EFFECTOR SCAFFOLDS, AND CELL-TARGETING MOLECULES FOR SITE-SPECIFIC CONJUGATION
#18 | 2020-07-23 ✅ Patent 11,713,347 granted on 2023-08-01CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors
#19 | 2020-03-19 ✅ Patent 10,668,047 granted on 2020-06-02Aziridine containing DNA alkylating agents
#20 | 2020-01-23CELL-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#21 | 2020-01-02CD20-BINDING IMMUNOTOXINS FOR INDUCING CELLULAR INTERNALIZATION AND METHODS USING SAME
#22 | 2019-12-19METHODS OF SCREENING, SELECTING, AND IDENTIFYING CYTOTOXIC RECOMBINANT POLYPEPTIDES BASED ON AN INTERIM DIMINUTION OF RIBOTOXICITY
#23 | 2019-11-28 ✅ Patent 11,104,707 granted on 2021-08-31Multivalent CD20-binding molecules comprising Shiga toxin a subunit effector regions and enriched compositions thereof
#24 | 2019-05-23MHC Class I Epitope Delivering Polypeptides
#25 | 2019-05-02 ✅ Patent 10,654,876 granted on 2020-05-19TH-302 solid forms and methods related thereto
#26 | 2019-02-28Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer
#27 | 2018-11-22 ✅ Patent 10,760,130 granted on 2020-09-01Predictive biomarker for hypoxia-activated prodrug therapy
#28 | 2018-10-11CELL-TARGETING MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL, SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS
#29 | 2018-09-13CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES
#30 | 2018-09-13De-Immunized, Shiga Toxin A Subunit Scaffolds and Cell-Targeting Molecules Comprising the Same
#31 | 2018-08-30CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#32 | 2018-03-01 ✅ Patent 10,392,425 granted on 2019-08-27Multivalent CD20-binding molecules comprising Shiga toxin A subunit effector regions and enriched compositions thereof
#33 | 2017-09-28 ✅ Patent 11,248,061 granted on 2022-02-15Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof
#34 | 2017-07-27 ✅ Patent 10,131,683 granted on 2018-11-20TH-302 solid forms and methods related thereto
#35 | 2017-05-25IMMUNOTHERAPY USING CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#36 | 2017-04-13 ✅ Patent 10,815,469 granted on 2020-10-27Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties
#37 | 2016-09-01 ✅ Patent 10,071,109 granted on 2018-09-11Predictive biomarker for hypoxia-activated prodrug therapy
#38 | 2016-01-21 ✅ Patent 10,450,354 granted on 2019-10-22CD20-binding immunotoxins for inducing cellular internalization and methods using same
#39 | 2015-09-17 ✅ Patent 11,142,584 granted on 2021-10-12CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
Also check out Molecular Templates, Inc.'s (Austin, United States) applicant profile with 26 patent applications submitted.
121016 ⎘